Search clinical trials for: Palbociclib
Total 344 results
-
PfizerCompletedBreast CancerAustralia, India
-
Abramson Cancer Center at Penn MedicineJohns Hopkins University; Pfizer; Translational Breast Cancer Research Consortium and other collaboratorsRecruitingBreast CancerUnited States
-
Washington University School of MedicinePfizerActive, not recruitingHead and Neck Squamous Cell CarcinomaUnited States
-
PfizerActive, not recruitingBreast NeoplasmsChina, Taiwan, Hong Kong, Singapore, Thailand
-
PfizerCompletedNeoplasms | Breast NeoplasmsJapan
-
Haukeland University HospitalPfizer; AstraZeneca; Helse VestActive, not recruitingBreast CancerNorway
-
Lebanese UniversityHaykel HospitalRecruitingCardiovascular Diseases | Immune System Diseases | Cancer | Breast Cancer | Hepatocellular Carcinoma | Lung Cancer | Chemotherapy | Solid Tumor | Prostate Cancer | Thromboembolism | Colon Cancer | Immunotherapy | Inflammatory DiseasesLebanon
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Spain, Denmark, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Brazil, Canada, China, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, India, Poland, Sweden, Italy
-
Peter MacCallum Cancer Centre, AustraliaRecruitingBreast Neoplasm FemaleAustralia
-
PfizerCompletedAdvanced Breast Cancer FemaleMexico, Argentina, Brazil, Colombia
-
Georgetown UniversityPfizerUnknownAdvanced Solid Tumor MalignanciesUnited States
-
National Taiwan University HospitalRecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone TherapyTaiwan
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Wake Forest University Health SciencesPfizer; Atrium Health Levine Cancer InstituteActive, not recruitingBreast Cancer | Female Breast CarcinomaUnited States
-
SanofiActive, not recruitingBreast CancerCzechia, Belgium, Spain, United States, France, Canada, Italy, Poland, Portugal, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine
-
SOLTI Breast Cancer Research GroupPfizerCompleted
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Merck Sharp & Dohme LLCCompletedFoot Infections in Diabetic Patients
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Tianjin Medical University Cancer Institute and...RecruitingBreast Cancer | Fulvestrant | PalbociclibChina
-
Hamdy A. AzimRecruitingPalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer (FATIMA)Metastatic Breast CancerSouth Africa
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Breast CancerUnited States
-
University Hospital Inselspital, BerneDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyTerminatedCOVID-19 | SARS-CoV InfectionBelgium, Switzerland, Italy
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, China, Spain, Hungary, Japan, Australia, Brazil, Italy, Slovakia, Switzerland
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
Theodoros FoukakisTerminatedBreast Cancer MetastaticSweden, United Kingdom
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
AstraZenecaCompletedAdvanced and Metastatic Breast CancerUnited States, United Kingdom
-
University of BirminghamPfizer; AstraZeneca; Mirati Therapeutics Inc.; Cancer Research UK; Experimental Cancer...Active, not recruitingAdenocarcinoma | Carcinoma, Squamous Cell | Non-Small Cell Lung CancerUnited Kingdom
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
European Organisation for Research and Treatment...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckFrance, Spain, Belgium, Italy, United Kingdom
-
PfizerCompletedBreast CancerKorea, Republic of, United States, Spain, Germany, Ireland, Hungary, Canada, France, Italy, Russian Federation, South Africa, Ukraine
-
Criterium, Inc.Recruiting
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Fudan UniversityRecruitingHER2-positive Breast Cancer | Estrogen Receptor-positive Breast CancerChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
University Medical Center GroningenNot yet recruitingRenal Cell Carcinoma | Breast Carcinoma | Thyroid Carcinoma | Ovarian Carcinoma | Endometrium CarcinomaNetherlands
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, China, Denmark, France, Hungary, Portugal, Spain, Taiwan, Thailand, Italy, Argentina, Brazil, Poland, Singapore, Germany, Greece, Hong Kong, Ukraine, Russian... and more
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, Peru and more
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Istituti Clinici Scientifici Maugeri SpACompletedFemale | Neoplasm Malignant | BreastItaly
-
Fondazione MichelangeloCompleted
-
PfizerCompletedMultiple MyelomaUnited States, Germany, Czech Republic
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States